- Home
- BLRX vs LLAP Comparison
BLRX vs LLAP Comparison
Compare BLRX & LLAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- LLAP
- Stock Information
- Founded
- BLRX 2003
- LLAP 2013
- Country
- BLRX Israel
- LLAP United States
- Employees
- BLRX N/A
- LLAP N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- LLAP Military/Government/Technical
- Sector
- BLRX Health Care
- LLAP Industrials
- Exchange
- BLRX Nasdaq
- LLAP Nasdaq
- Market Cap
- BLRX 54.1M
- LLAP 50.3M
- IPO Year
- BLRX 2011
- LLAP N/A
- Fundamental
- Price
- BLRX $0.46
- LLAP $0.25
- Analyst Decision
- BLRX Strong Buy
- LLAP Buy
- Analyst Count
- BLRX 2
- LLAP 3
- Target Price
- BLRX $11.50
- LLAP $2.58
- AVG Volume (30 Days)
- BLRX 308.2K
- LLAP 5.3M
- Earning Date
- BLRX 11-18-2024
- LLAP 11-12-2024
- Dividend Yield
- BLRX N/A
- LLAP N/A
- EPS Growth
- BLRX N/A
- LLAP N/A
- EPS
- BLRX N/A
- LLAP N/A
- Revenue
- BLRX $17,048,000.00
- LLAP $133,107,000.00
- Revenue This Year
- BLRX N/A
- LLAP $8.71
- Revenue Next Year
- BLRX N/A
- LLAP $34.59
- P/E Ratio
- BLRX N/A
- LLAP N/A
- Revenue Growth
- BLRX N/A
- LLAP 10.75
- 52 Week Low
- BLRX $0.43
- LLAP $0.23
- 52 Week High
- BLRX $1.93
- LLAP $1.62
- Technical
- Relative Strength Index (RSI)
- BLRX 26.70
- LLAP 35.70
- Support Level
- BLRX $0.43
- LLAP $0.25
- Resistance Level
- BLRX $0.56
- LLAP $0.26
- Average True Range (ATR)
- BLRX 0.05
- LLAP 0.01
- MACD
- BLRX -0.01
- LLAP 0.01
- Stochastic Oscillator
- BLRX 12.42
- LLAP 21.43
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About LLAP Terran Orbital Corporation
Terran Orbital Corp is a manufacturer of satellite products primarily serving the aerospace and defense industries. The company provide end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of our military, civil, and commercial customers. Geographically company operates in United States and Europe. Majority of the revenue is generated from United States.